Relationship between the upper limit of vulnerability determined in normal sinus rhythm and the defibrillation threshold in patients with implantable cardioverter defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 4 I, 1998, Pages 687-693

  Hui, Richard C ^a   Rosenthal, Larry ^a   Ramza, Brian ^a   Nsah, Emmanuel ^a   Lawrence, John ^a   Tomaselli, Gordon ^a   Berger, Ronald ^a   Calkins, Hugh ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Defibrillation threshold; Implantable cardioverter defibrillator; Upper limit of vulnerability

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PULSE GENERATOR; SINUS RHYTHM;

ANTI-ARRHYTHMIA AGENTS; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; VENTRICULAR FIBRILLATION;

EID: 0031969490     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb00124.x     Document Type: Article

References (34)

1. Mirowski M, Reid PR, Mower M, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303:322-324.
2. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: Effect of encanide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406-412.
3. Coplen SE, Antmann EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized controlled trials. Circulation 1990; 82:1106-1116.
4. Stroke Prevention in Atrial Fibrillation Investigators: The Stroke Prevention in Atrial Fibrillation Study: Final results. Circulation 1991; 84:527-539.
5. Lehmann MH, Steinman RT, Schuger CD, et al. Defibrillation threshold testing and other practices related to AICD implantation: Do all roads lead to Rome? PACE 1989; 12:1530-1537.
6. Singer I, Van Der Laken J, Edmonds H, et al. Is defibrillation testing safe? PACE 1991; 14:1899-1904.
7. Lerman B, Engelstein E. Metabolic determinants of defibrillation. Circulation 1995; 91:838-844.
8. Bernstein R, Raymond L, Onufer J, et al. Clinical determination of the 80% effective defibrillation voltage: A new Bayesian up-down protocol for defibrillation threshold testing. (abstract) Circulation 1994; 90:1-653.
9. Frame R, Brodman R, Furman S, et al. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. PACE 1992; 15:870-877.
10. Chen P-S, Shibata N, Dixon EG, et al. Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability. Circulation 1986; 73:1022-1028.
11. Shibata N, Chen P-S, Dixon EG, et al. Influence of epicardial shock strength and timing on the induction of ventricular arrhythmias in dogs. Am J Physiol 1988; 255:H891-901.
12. Chen P-S, Feld GK, Kriett JM, et al. Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation 1993; 88: 186-192.
13. Idriss SF, Anstadt MP, Anstadt GL, et al. The effect of cardiac compression on defibrillation efficacy and the upper limit of vulnerability. J Cardiovasc Electrophysiol 1995; 6:368-378.
14. Swartz JF, Karasik PE, Bacon ME, et al: Relationship of upper limit of vulnerability to defibrillation threshold for monophasic and biphasic waveform human nonthoractomy defibrillation. (abstract) J Am Coll Cardiol 1994; 23:293A.
15. Lesigne C, Levy B, Saumont R, et al. An energy-time analysis of ventricular fibrillation and defibrillation thresholds with internal electrodes. Med Biol Eng 1976; 14:617-622.
16. Lemke B, Calcum B, Dryander S, et al. Judgement on the probability for defibrillation based on the "upper limit of vulnerability." (abstract) PACE 1995; 18:947.
17. Swerdlow CD, Ahern T, Chen P-S. Comparative reproducibility of defibrillation threshold and upper limit of vulnerability. (abstract) PACE 1995; 18:835.
18. Hwang C, Swerdlow CD, Kass RM, et al. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation 1994; 90: 2308-2314.
19. Swerdlow CD, Ahern T, Kass RM, et al. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter defibrillators. J Am Coll Cardiol 1996; 27:1112-1118.
20. Singer I, Lang D. Defibrillation Threshold: Clinical Utility and Therapeutic Implications. PACE 1992; 15:932-949.
21. McDaniel W, Schuder J. An up-down algorithm for estimation of the cardiac ventricular defibrillation threshold. Med Instrum 1988; 22:298-303.
22. Chen P-S, Wolf PD, Ideker RE. Mechanism of cardiac defibrillation. Circulation 1991; 84:913-919.
23. Mower MM, Mirowski M, Spear JF, et al. Patterns of ventricular activity during catheter defibrillation. Circulation 1974; 49:858-861.
24. Zipes DP, Fischer PJ, King RM, et al. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol 1975; 36:37-44.
25. Chen P-S, Wolf PD, Melnick SD, et al. Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open chest dogs. Circ Res 1990; 66:1544-1560.
26. Kavanagh KM, Harrison JH, Dixon EG, et al. Correlation of the probability of success curves for defibrillation and for the upper limit of vulnerability. (abstract) PACE 1990; 13:536.
27. Chen P-S, Feld GK, Mower M, et al: Effects of pacing rate and timing of defibrillation shock on the relation between the defibrillation threshold and the upper limit of vulnerability in open chest dogs. J Am Coll Cardiol 1991; 18:1555-1563.
28. Souza JJ, Malkin RA, Ideker RE. Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system. Circulation 1995; 91:1247-1252.
29. Fabritz CL, Kirchhof PF, Behrens S, et al. Myocardial vulnerability to T wave shocks: Relation to shock strength, shock coupling interval, and dispersion of ventricular repolarization. J Cardiovasc Electro 1996; 7:231-242.
30. Walker RG, Idriss SF, Malkin RA, et al. Comparison of methods for determining the upper limit of vulnerability, (abstract) Circulation 1993; 88:1-593.
31. Spach MS, Barr RC. Analysis of ventricular activation and repolarization from intramural and epicardial potential distribution for ectopic beats in intact dogs. Circ Res 1975; 37:830-843.
32. Abildskov JA. Effects of activation sequence on the local recovery of ventricular excitability in the dog. Circ Res 1976; 38:240-243.
33. Osaka T, Kodama I, Tsuboi N. Effects of activation sequence and anisotropic cellular geometry on the repolarization phase of action potential of dog ventricular muscle. Circulation 1987; 76:226-236.
34. Fan W, Gotoh M, Chen P-S. Effects of the pacing site, procainamide, and lead configuration on the relationship between the upper limit of vulnerability and the defibrillation threshold. PACE 1995; 18:1279-1284.